Letters to our shareholders

loader
1st-cover-Letter-shareholders-september-2021-oncodesign
01/09/2021

Letter to the Shareholders – September 2021

Here is our September issue which echoes our #InvestorDay 2021. As usual, Philippe Genne has concocted an editorial entitled “Little GrassHopper”: a philosophical angle on the meaning of life and the importance of the individual in society.

20/11/2020

Letter to our shareholders – November 2020

“Hunting in packs, a collaborative commercial approach hard-wired into Oncodesign’s genes” – Philippe Genne, President and CEO of Oncodesign.

01/04/2020

Letter to our shareholders – April 2020

Here is our April 2020 issue which details the new organization of the Group into 3 Business Units. Interviews and articles on the menu. Anatomy of the new face of Oncodesign: BU Service, BU Biotech & BU Artificial Intelligence. Without forgetting the editorial by Ph. Genne entitled “how much is…

01/11/2019

Letter to our shareholders – November 2019

“The alignment of planets is more topical than ever at the end of the year, with all due respect to the spell casters.” says Philippe Genne, CEO & founder, Oncodesign.

01/06/2019

Letter to our shareholders – June 2019

“The health sector is in great need of innovations, & will continue to be for a long time yet” says Philippe Genne, CEO & founder, Oncodesign.

01/11/2018

Letter to our shareholders – November 2018

“I urge you all to stay aboard and keep your eyes firmly fixed on the future:  we believe in it” says Philippe Genne, CEO & founder, Oncodesign.

01/06/2018

Letter to our shareholders – June 2018

“Step by step, we are building our future with innovation” says Philippe Genne, CEO & founder, Oncodesign.